Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.83092 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.68085 | 62 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.66537 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.50707 | 59 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.60531 | 61 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.81485 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.90563 | 64 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.672 | 61 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.59615 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.62726 | 61 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.6801 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.60792 | 61 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.6916 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.68163 | 62 |